Available until March 5, 2026 - Online CME Course

Mayo Clinic's Ophthalmology Grand Rounds has been repurposed as an online offering for ophthalmologists, optometrists, physicians, physician assistants, nurse practitioners and nurses who are interested in learning more about a variety of medical and surgical conditions in ophthalmology.

Available until March 5, 2026 - Online CME Course

Mayo Clinic's Ophthalmology Grand Rounds has been repurposed as an online offering for ophthalmologists, optometrists, physicians, physician assistants, nurse practitioners and nurses who are interested in learning more about a variety of medical and surgical conditions in ophthalmology.

Available until May 31, 2026 - Online CME Course

The Mayo Clinic Sports Medicine Board Review online course is a one of a kind course designed to provide a comprehensive review of all subjects tested on the sports medicine board examination. The course faculty includes internationally recognized experts in the field of sports medicine. Taking this online course increases the attendee’s sports medicine knowledge and assists in their preparation for the sports medicine board examination and the clinical practice of sports medicine.

Available until February 1, 2026

Severe acute respiratory syndrome coronavirus 2, also known as COVID-19, is a novel virus with a rapidly changing genotype. It’s responsible for over a million deaths so far. One of every 300 Americans have died as a result of the virus and infection with COVID-19, and it has been responsible for a reduction in life expectancy in the U.S. for both 2021 and 2022. There are 4 widely available, approved vaccines in the United States, yet an inadequate number of individuals have been immunized and very few are still wearing protective masks. The consequences of this include continued excess morbidity and mortality as well as the development of a variety of new variants of the virus. Our guest for this podcast is Greg A. Poland, M.D., an internist, and the director of vaccine research at the Mayo Clinic. He’s also the lead author of an article published in Mayo Clinic Proceedings in December 2022. The article is entitled “Year 3 of COVID-19: Harsh Truths, Brutal Realities and Glimmers of Hope”. We’ll be discussing some of the key points from this article.

Available until May 7, 2027 - Podcast Online CME Education

Kennedy C. Concannon, Pharm.D., R.Ph. describes the current standard of care for primary cytomegalovirus (CMV) prophylaxis in solid organ transplant (SOT) recipients and evaluate outcomes associated with letermovir use for primary CMV prophylaxis in SOT recipients. Also, identifying letermovir’s place in therapy and practical considerations for use in clinical practice.

COVID-19 Small Molecule Drug Discovery

Recorded: February 22, 2022 at 12:00pm - 1:30pm ET

On Tuesday, February 22, from 12:00 p.m.-1:30 p.m. ET, Mayo Clinic and other experts discuss the challenges and opportunities of small molecule drug discovery and treatments to disrupt viral progression of SARS-CoV-2. The state of the art in antivirals to treat COVID-19 will also be reviewed.